Autism Spectrum Disorder Diagnostics Market Report 2026

Autism Spectrum Disorder Diagnostics Market Overview

• Autism Spectrum Disorder Diagnostics market size has reached to $28.87 billion in 2025 • Expected to grow to $36.76 billion in 2030 at a compound annual growth rate (CAGR) of 4.9% • Growth Driver: Growth In Specialized Diagnostic Centers Drives Expansion Of Autism Spectrum Disorders Diagnostic Market • Market Trend: Innovative Technologies And Tools Enhance Early Detection And Diagnosis • Asia-Pacific was the largest region in 2025.

What Is Covered Under Autism Spectrum Disorder Diagnostics Market?

Autism spectrum disorder (ASD) diagnostics refer to the range of methods and tools used to identify and assess individuals suspected of having autism spectrum disorder. The goal of ASD diagnostics is to accurately identify the presence and severity of ASD symptoms, facilitate early intervention, and guide personalized treatment plans. These assessments are conducted by healthcare professionals specializing in neurodevelopmental disorders and are crucial for providing timely support and services to individuals on the autism spectrum and their families. The main types in the autism spectrum disorder diagnostics market are autistic disorder, Asperger syndrome, pervasive development disorder (PDD), and others. Autistic disorder is a neurodevelopmental disorder characterized by challenges in social interaction, communication, and repetitive behaviors. The various services include behavioral approaches, early intervention, medication, and others and different distribution channels including hospital pharmacies, drug stores and retail pharmacies, and online pharmacies.

What Is The Autism Spectrum Disorder Diagnostics Market Growth Forecast?

The autism spectrum disorder diagnostics market size is expected to see steady growth in the next few years. It will grow to $36.76 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to rising demand for early intervention services, increasing use of ai-assisted diagnostic tools, expansion of tele-diagnostics platforms, growing investment in neurodevelopmental research, improved standardization of diagnostic criteria. Major trends in the forecast period include increasing adoption of digital screening tools, growing use of standardized behavioral assessment scales, expansion of early childhood diagnostic programs, rising integration of multidisciplinary diagnostic approaches, enhanced focus on early and accurate detection.

Global Autism Spectrum Disorder Diagnostics Market Segmentation

1) By Diagnostic Method: Behavioral And Developmental Screening Tools, Standardized Diagnostic Assessments, Genetic And Molecular Testing, Digital And AI-Based Diagnostic Tools 2) By Test Type: Observational And Questionnaire-Based Tests, Cognitive And Neurodevelopmental Assessments, Biomarker And Genetic Tests, Eye-Tracking And Sensor-Based Tests 3) By Age Group: Infants And Toddlers (0–3 years), Children (4–12 years), Adolescents And Adults 4) By End User: Hospitals And Specialty Clinics, Diagnostic And Reference Laboratories, Academic And Research Institutes Subsegments: 1) By Behavioral And Developmental Screening Tools: Parent-Reported Screening Questionnaires, Clinician-Administered Developmental Checklists 2) By Standardized Diagnostic Assessments: Structured Behavioral Observation Assessments, Standardized Diagnostic Interviews 3) By Genetic And Molecular Testing: Chromosomal Microarray Analysis (CMA), Next-Generation Sequencing (NGS) Panels 4) By Digital And AI-Based Diagnostic Tools: AI-Driven Behavioral Analysis Platforms, Digital Biomarker & Eye-Tracking Systems

What Is The Driver Of The Autism Spectrum Disorder Diagnostics Market?

The growth in specialized diagnostic centers is expected to propel the growth of the autism spectrum disorders diagnostic market going forward. An autism-specialized diagnostic center is a facility staffed with healthcare professionals, psychologists, and specialists who conduct comprehensive evaluations and assessments to diagnose autism spectrum disorder. The growth in specialized diagnostic centers is due to diagnostic advancements, demand for comprehensive care, professional training, research, and recognition of autism as a public health priority. Specialized diagnostic centers play a pivotal role in improving diagnostic accuracy, facilitating early intervention, and enhancing outcomes for individuals with ASD by providing specialized expertise, advanced diagnostic tools, comprehensive assessments, tailored treatment plans, family support, and opportunities for research collaboration. For instance, in July 2025, according to NHS England, the U.K.-based government agency delivering health services, the national Community Diagnostic Centre (CDC) Programme has approved 170 CDC sites across England. As of August 2024, 165 sites are operational in a variety of settings; of these, 135 are operating from their permanent CDC building, and the rest are operating from temporary capacity while the CDC building is completed. Therefore, growth in specialized diagnostic centers is driving the growth of the autism spectrum disorders diagnostic market.

Key Players In The Global Autism Spectrum Disorder Diagnostics Market

Major companies operating in the autism spectrum disorder diagnostics market are Quest Diagnostics, Laboratory Corporation of America LabCorp, ARUP Laboratories, Invitae, Natera, Fulgent Genetics, Myriad Genetics, Sema4, PreventionGenetics, Color Genomics, Cognoa, EarliTec Diagnostics, Eurofins Scientific, Sonic Healthcare, Cerba HealthCare, Baylor Genetics, Mayo Clinic Laboratories, Bionano Genomics, Genomind, Blueprint Genetics

Global Autism Spectrum Disorder Diagnostics Market Trends and Insights

Major companies operating in the autism spectrum disorder diagnostics market are developing advanced solutions such as devices that are using Dynamic Quantification of Social-Visual Engagement (DQSVE) to gain a competitive edge. It captures and analyzes a child's moment-by-moment looking behavior at a rate of 120 times per second. For instance, in September 2023, Marcus Autism Center, a US-based nonprofit healthcare and research organization, launched the EarliPoint™ Evaluation, a pioneering FDA-authorized device designed for the early diagnosis of autism spectrum disorder (ASD) in children aged 16 to 30 months. This innovative tool utilizes eye-tracking technology to assess children's social interactions, significantly reducing the time required for diagnosis from hours to approximately 12 minutes.

What Are Latest Mergers And Acquisitions In The Autism Spectrum Disorder Diagnostics Market?

In March 2024, Fletch Equity LLC, a US-based private equity firm, acquired Autism Spectrum Interventions (ASI) for an undisclosed amount. The acquisition by Fletch Equity aims to bolster ASI's growth and expansion across California and potentially into neighboring states. Autism Spectrum Interventions (ASI) is a US-based provider of applied behavior analysis (ABA) therapy specializing in services for children with autism spectrum disorder (ASD).

Regional Outlook

Asia-Pacific was the largest region in the autism spectrum disorder diagnostics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Autism Spectrum Disorder Diagnostics Market?

The autism spectrum disorder (ASD) diagnostics market consists of revenues earned by entities by providing services such as behavioral assessments, genetic testing, speech and language evaluations, and psychological assessments. The market value includes the value of related goods sold by the service provider or included within the service offering. The autism spectrum disorder (ASD) diagnostics market also includes sales of diagnostic tests and kits, neuroimaging equipment, and behavioral assessment tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Autism Spectrum Disorder Diagnostics Market Report 2026?

The autism spectrum disorder diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the autism spectrum disorder diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.